SCHEMBL24080898

SCHEMBL24080898

CCOC(=O)CCNC(=O)c1cc(Br)c[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CREBBP Q92793 1/20 0.51
▸ CYP1A2 P05177 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ DAO P14920 1/20 0.46
▸ HRH3 Q9Y5N1 5/20 0.45
▸ ADRA2A P08913 1/20 0.44
▸ ADRA1D P25100 1/20 0.44
▸ VIP P01282 1/20 0.41
▸ KCNA6 P17658 1/20 0.40
▸ KCNA3 P22001 1/20 0.40
▸ KCNA4 P22459 1/20 0.40
▸ KCNA5 P22460 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ HPGD P15428 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7845382 0.80 PKM (0.60) CREBBPPKMDAOHRH3ADRA2A
SCHEMBL3425306 0.78 CYP1A2 (0.46) CYP1A2CYP3A4CYP2C19DAOKCNA6
SCHEMBL12999930 0.77 GPR84 (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1HPGD
SCHEMBL13222147 0.76 KDM4E (0.54) KDM4E
SCHEMBL15243719 0.75 KCNA6 (0.51) CREBBPCYP3A4PKMDAOHRH3
SCHEMBL1827611 0.75 HDAC1 (0.60) HRH3ALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL2544551 0.75 CREBBP (0.51) CREBBPPKMALDH1A1HPGDSMN1; SMN2
SCHEMBL23782641 0.74 HPGD (0.61) CYP1A2CYP3A4CYP2C19ALDH1A1HPGD
SCHEMBL12999915 0.73 ENPP2 (0.43) CYP1A2CYP3A4CYP2C19ALDH1A1HPGD
SCHEMBL12999481 0.73 ALDH1A1 (0.45) CYP1A2CYP3A4CYP2C19ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3707142-B1 PYRROLOPYRAZINE DERIVATIVES AS ALPHA V INTEGRIN INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-12-08 — — EP disclosed
Send feedback